5Gemand W, Solnica B, Naskalski JW. An example of a bootstrap technique application for judging a variability of method performance estimates and its consequences for quality control planning [J]. Clin Chim Acta, 2007, 384( 1-2): 160- 162.
6Medicare, Medicaid,and CLIA programs;extension of certain effective dates for clinical laboratory requirements under CLIA. Centers for Disease Control and Prevention (CDC) and Health Care Financing Administration (HCFA), HHS. Final rule with comment period [S]. Fed Regist,2000,65(251):82941-82944.
7Briggs C, Kunka S, Pennaneach C. Performance evaluation of a new compact hematology analyzer, the Sysmex pocH- 100i [J]. Lab Hematol,2003,9(4):225-233.
8National Committee for Clinical Laboratory Standards. Leukocyte Differential Counting NCCLS Approved Standard H20-A2 [S].Villanova,PA, 1992.
9National Committee for Clinical Laboratory Standards.How to define and reference intervals in the clinical laboratory NCCLS Approved Guideline C28-A2[S].Wayne,PA,2000.
